UBS Group’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-955
| Closed | -$5.49K | – | 9359 |
|
|
2025
Q1 | $5.49K | Buy |
+955
| New | +$5.49K | ﹤0.01% | 7672 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8617 |
|
|
2024
Q3 | – | Hold |
0
| – | -$1 | – | 8786 |
|
|
2024
Q2 | – | Sell |
-439
| Closed | -$6.05K | – | 8275 |
|
|
2024
Q1 | $6.05K | Buy |
439
+421
| +2,339% | +$5.81K | ﹤0.01% | 6314 |
|
|
2023
Q4 | $153 | Sell |
18
-54
| -75% | -$459 | ﹤0.01% | 7646 |
|
|
2023
Q3 | $617 | Sell |
72
-45
| -38% | -$386 | ﹤0.01% | 7230 |
|
|
2023
Q2 | $1.5K | Buy |
+117
| New | +$1.5K | ﹤0.01% | 6823 |
|
|
2022
Q4 | – | Sell |
-119
| Closed | -$1K | – | 9825 |
|
|
2022
Q3 | $1K | Sell |
119
-330
| -73% | -$2.77K | ﹤0.01% | 8940 |
|
|
2022
Q2 | $4K | Buy |
+449
| New | +$4K | ﹤0.01% | 8098 |
|
|
2022
Q1 | – | Sell |
-527
| Closed | -$11K | – | 9634 |
|
|
2021
Q4 | $11K | Buy |
527
+465
| +750% | +$9.71K | ﹤0.01% | 7573 |
|
|
2021
Q3 | $2K | Buy |
+62
| New | +$2K | ﹤0.01% | 7842 |
|